|
N=18,826 |
N=1,672 |
N=1,862 |
|
Recipient Characteristics |
|
|
|
|
Recipient Age (years) |
57 (47-63) |
56 (46-63) |
56 (45-62) |
<0.001 |
Female |
5,142 (27.3%) |
397 (23.7%) |
413 (22.2%) |
<0.001 |
Race |
|
|
|
|
White |
12,427 (66.4%) |
1,122 (67.5%) |
1,124 (60.8%) |
<0.001 |
Black |
3,930 (21.0%) |
371 (22.3%) |
505 (27.3%) |
|
Hispanic |
1,557 (8.3%) |
132 (7.9%) |
158 (8.5%) |
|
Asian |
693 (3.7%) |
29 (1.7%) |
50 (2.7%) |
|
Other |
115 (0.6%) |
8 (0.5%) |
12 (0.6%) |
|
BMI at Waitlisting (kg/m2) |
27.32 (4.82) |
30.02
(5.24) |
26.01 (4.39) |
<0.001 |
BMI at Transplant (kg/m2) |
27.32 (4.81) |
26.76
(4.64) |
29.39 (4.84) |
<0.001 |
Recipient Blood Type |
|
|
|
|
A |
7,747 (41.2%) |
595 (35.6%) |
662 (35.6%) |
<0.001 |
AB |
1,156 (6.1%) |
67 (4.0%) |
58 (3.1%) |
|
B |
2,878 (15.3%) |
231 (13.8%) |
240 (12.9%) |
|
O |
7,045 (37.4%) |
779 (46.6%) |
902 (48.4%) |
|
Heart Failure Etiology |
|
|
|
|
Non-Ischemic |
9,775 (52.0%) |
887 (53.1%) |
1,037 (55.7%) |
<0.001 |
Ischemic |
6,450 (34.3%) |
528 (31.6%) |
665 (35.7%) |
|
Congenital |
559 (3.0%) |
50 (3.0%) |
50 (2.7%) |
|
Restrictive |
695 (3.7%) |
69 (4.1%) |
31 (1.7%) |
|
Valvular |
257 (1.4%) |
22 (1.3%) |
16 (0.9%) |
|
Hypertrophic |
512 (2.7%) |
57 (3.4%) |
27 (1.5%) |
|
Other |
30 (0.2%) |
5 (0.3%) |
1 (0.1%) |
|
Diabetes Mellitus |
5,172 (27.6%) |
503 (30.2%) |
514 (27.6%) |
0.076 |
Total Bilirubin (mg/dL) |
0.98 (1.62) |
0.99 (1.48) |
0.86 (1.12) |
0.006 |
Serum Creatinine (mg/dL) |
1.23 (0.61) |
1.24 (0.48) |
1.24 (0.40) |
0.94 |
Positive CMV Serology |
10,514 (55.8%) |
899 (53.8%) |
1,072 (57.6%) |
0.075 |
Transfusion on Waitlist |
3,527 (19.3%) |
608 (37.8%) |
675 (37.5%) |
<0.001 |
Pretransplant Mechanical Ventilation |
245 (1.3%) |
15 (0.9%) |
9
(0.5%) |
0.004 |
Pretransplant Intensive Care Unit |
6,148 (32.7%) |
555 (33.2%) |
235
(12.6%) |
<0.001 |
Intravenous Inotropes |
7,078 (37.6%) |
559 (33.4%) |
320 (17.2%) |
<0.001 |
Pretransplant Intra-Aortic Balloon Pump |
1,954 (10.4%) |
154 (9.2%) |
60 (3.2%) |
<0.001 |
Pretransplant Extracorporeal Membrane Oxygenation |
253 (1.3%) |
21
(1.3%) |
1 (0.1%) |
<0.001 |
Ventricular Assist |
|
|
|
|
None |
10,729 (57.7%) |
747 (45.2%) |
413 (22.4%) |
<0.001 |
LVAD |
7,329 (39.4%) |
770 (46.6%) |
1,379 (74.9%) |
|
RVAD |
35 (0.2%) |
4 (0.2%) |
3 (0.2%) |
|
TAH |
159 (0.9%) |
58 (3.5%) |
16 (0.9%) |
|
LVAD + RVAD |
330 (1.8%) |
74 (4.5%) |
31 (1.7%) |
|
Transplant Characteristics |
|
|
|
|
Sex Matched |
14,267 (75.8%) |
1,314 (78.6%) |
1,468 (78.8%) |
<0.001 |
Race Matched |
9,696 (51.5%) |
861 (51.5%) |
920 (49.4%) |
0.22 |
HLA Matched |
2,428 (12.9%) |
231 (13.8%) |
239 (12.8%) |
0.56 |
ABO Matched |
15,761 (83.7%) |
1,448 (86.6%) |
1,688 (90.7%) |
<0.001 |
CMV Matched |
9,946 (53.1%) |
857 (51.4%) |
989 (53.5%) |
0.40 |
Donor Distance (nautical miles) |
101 (14-303) |
102 (15-289) |
86
(12-271) |
0.004 |
Cold Ischemic Time (hours) |
3.2 (2.4-3.8) |
3.2 (2.5-3.8) |
3.1
(2.4-3.8) |
0.15 |
Days Listed |
74 (21-230) |
220 (91-504) |
417 (212-758) |
<0.001 |